Asphalion MedTech had the honor of participating in the 2nd Congress of the Catalan Pain Society (Societat Catalana de Dolor – SCD), which took place recently in Barcelona. The congress served as an excellent platform, bringing together healthcare professionals from a wide range of specialties to share knowledge, latest advances, and future perspectives on pain management — from Primary Care to highly specialized Pain Units.
During the congress, Asphalion took part in the roundtable discussion titled “The Digital Revolution in Health: Opportunities and Challenges of Digital Therapeutics.” Our MedTech regulatory expert, Fran Rodríguez, contributed with valuable insights on regulatory strategies critical for the successful development and market access of Digital Therapeutics (DTx) and innovative medical technologies.
Key points addressed during the session included the importance of establishing regulatory frameworks that not only secure CE marking but also ensure real and timely access of medical devices to the patients who need them. Our expert emphasized that a strong understanding of the state of the art, combined with early integration of feedback from healthcare professionals and end-users, is crucial to designing medical devices that are safe, effective, and aligned with clinical needs.
This roundtable also highlighted the growing relevance of Digital Therapeutics (DTx) and Artificial Intelligence (AI) as transformative tools in pain management, opening new avenues for personalized, data-driven healthcare solutions.
We are proud to have been part of this dynamic and forward-looking event, contributing to the broader conversation about the future of healthcare innovation and patient-centered therapeutic approaches.
If you are developing a Medical Device and need expert support in regulatory affairs, digital health solutions, or market access strategies, Asphalion is here to help you.
Contact us at: [email protected]
